|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Ciba-Geigy
gptkb:Searle_Pharmaceuticals
|
|
gptkbp:approves
|
gptkb:1975
gptkb:FDA
|
|
gptkbp:brand
|
Klonopin
|
|
gptkbp:contraindication
|
gptkb:Insurance_Company
severe respiratory insufficiency
acute narrow-angle glaucoma
hypersensitivity to benzodiazepines
|
|
gptkbp:developed_by
|
gptkb:Roche
|
|
gptkbp:duration
|
short-term
long-term
|
|
gptkbp:environmental_impact
|
high
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Clonazepam
|
|
gptkbp:indication
|
gptkb:psychologist
gptkb:restless_legs_syndrome
muscle spasms
|
|
gptkbp:ingredients
|
C15 H10 Cl N3 O
|
|
gptkbp:interacts_with
|
gptkb:beer
antidepressants
opioids
|
|
gptkbp:is_available_in
|
many countries
|
|
gptkbp:is_available_on
|
gptkb:tablet
oral solution
disintegrating tablet
|
|
gptkbp:is_used_for
|
anxiety
panic disorder
seizure disorders
|
|
gptkbp:legal_issue
|
controlled substance
|
|
gptkbp:lifespan
|
30 to 40 hours
|
|
gptkbp:manager
|
oral
intravenous
|
|
gptkbp:marketed_as
|
various brand names
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pharmacokinetics
|
highly protein-bound
lipophilic
crosses blood-brain barrier
GABA receptor agonist
|
|
gptkbp:related_to
|
gptkb:diazepam
alprazolam
lorazepam
|
|
gptkbp:requires
|
gptkb:theorem
|
|
gptkbp:side_effect
|
gptkb:historical_event
dizziness
confusion
drowsiness
|
|
gptkbp:symptoms
|
anxiety
seizures
insomnia
|
|
gptkbp:tradition
|
can develop
|
|
gptkbp:type_of
|
1622-61-3
|